BETA: Please send your feedback!
Natera
NTRA:NAS
Biotechnology
$0
SMALL cap
$35.35
(-0.36%)
0.05%
since start of 2020
-19.02
- —
- 1
- 2
- 3
- 4
- 5
About
Biotechnology
Founded 2003
Natera, Inc. engages in the discovery, development, and commercialization of genetic testing services. It offers Panorama Non-Invasive Prenatal Test; Horizon Carrier Screening; Spectrum Pre-implantation Genetic Screening and Spectrum Pre-implantation Genetic Diagnosis; Anora Products of Conception; and Non-Invasive Paternity Testing. The company was founded by Matthew Rabinowitz and Jonathan Sheena in November 2003 and is headquartered in San Carlos, CA.
website
Headquarters
Executives
| Name | Title | Gender |
| Matthew Rabinowitz, PhD | Chairman, President & Chief Executive Officer | Male |
| Jonathan Sheena | Director & Chief Technology Officer | Male |
| Daniel Rabinowitz | Secretary & General Counsel | Male |
| Mike Brophy, MBA | CFO, Director & Head-Investor Relations | Male |
| Damon Silvestry | Vice President-Operations | Male |
| Michael C. Little, PhD | Senior Vice President-Research & Development | Male |
| Joshua Leichter | Vice President-Legal & Corporate Affairs | Male |
| Cheng-Ho Lin, PhD | Chief Scientific Officer | null |
Mindful Investing Summary
- —
- 1
- 2
- 3
- 4
- 5
Natera - Competitors and Related Companies
How Natera stacks up to its peers in the Biotechnology industry or with competing business segments.
Natera
NTRA:NAS
Biotechnology
$0
SMALL cap
$35.35
(-0.36%)
0.05%
since start of 2020
-19.02
Paratek Pharmaceuticals
PRTK:NAS
Biotechnology
$116.84mm
SMALL cap
$3.51
(-0.01%)
-0.12%
since start of 2020
-0.92
Prothena
PRTA:NAS
Biotechnology
$531.03mm
SMALL cap
$13.31
(0.20%)
-0.13%
since start of 2020
-6.75
Pluristem Therapeutics
PSTI:NAS
Biotechnology
$57.66mm
MICRO cap
$3.67
(-0.13%)
-0.08%
since start of 2020
-1.42
Vertex Pharmaceuticals
VRTX:NAS
Biotechnology
$58.47bn
LARGE cap
$227.37
(-1.69%)
0.03%
since start of 2020
27.07